Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation

Table 5 Tacrolimus intra-patient variability in pancreas and bone marrow transplantation: Main findings

Kidney and pancreas, and bone marrow transplant
Ref.	Sample size	Donor type	Tac-IPV Assessment	Outcome
Torabi et al[69], 2020	39	Both living and deceased donor	CV	The once daily LCPT dosing may facilitate medication adherence and result in improved long-term outcomes
Marco et al[70], 2022	128	Living donor only	CV	Determination of Tac IPV soon after alloHSCT could be useful in identifying greater risks of aGVHD

CV: Coefficient of variation; LCPT: LCP-tacrolimus; alloHSCT: Allogeneic stem cell transplantation; aGVHD: Acute graft-vesus-host disease.